# A4GNT

## Overview
The A4GNT gene encodes the enzyme alpha-1,4-N-acetylglucosaminyltransferase, a type II transmembrane protein that plays a pivotal role in the biosynthesis of mucin-type O-glycans. This enzyme is primarily active in the Golgi apparatus of mucous cells, where it facilitates the transfer of N-acetylglucosamine to beta-galactose residues, forming specific glycan structures essential for the protective and lubricative properties of mucosal surfaces in the stomach and duodenum (Nakayama1999Expression; Unknownauthors2014Handbook). The A4GNT gene is located on chromosome 3p14.3 and is crucial for maintaining the integrity of the gastric mucosal barrier, protecting against pathogens, and preventing gastric tumorigenesis (Nakayama1999Expression; Unknownauthors2014Handbook). Alterations in the expression of A4GNT have significant clinical implications, particularly in the context of gastric cancer, highlighting its role as a potential tumor suppressor (Nakayama2016Function; Kawakubo2019Analysis).

## Structure
The human A4GNT protein, also known as alpha-1,4-N-acetylglucosaminyltransferase, consists of 340 amino acids and is characterized by a type II transmembrane topology. This structure includes a short cytoplasmic NH2-terminus, a 22 amino acid transmembrane/signal anchoring domain, and a large COOH-terminus that contains both stem and catalytic domains (Nakayama2002α4NAcetylglucosaminyltransferase; Unknownauthors2014Handbook). The catalytic domain of A4GNT features four potential N-glycosylation sites, which are common post-translational modifications that can influence the enzyme's function and stability (Nakayama2002α4NAcetylglucosaminyltransferase; Zhang2001Immunohistochemical).

The enzyme is involved in the synthesis of specific glycan structures, particularly in gastric and duodenal glands, and shows a preference for core 2 branched oligosaccharides. It efficiently acts on beta-1,4 or beta-1,3 linked Gal residues on O-glycans (Nakayama2002α4NAcetylglucosaminyltransferase; Nakayama1999Expression). The enzyme's activity is crucial for the formation of GlcNAcα1→4Galβ→R structures, which are associated with mucin core proteins such as MUC5AC and MUC6 in gastric mucin (Zhang2001Immunohistochemical). The A4GNT gene is located on chromosome 3p14.3 (Nakayama1999Expression).

## Function
The A4GNT gene encodes the enzyme alpha-1,4-N-acetylglucosaminyltransferase, which plays a crucial role in the biosynthesis of mucin-type O-glycans. This enzyme facilitates the transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to beta-galactose (βGal) residues with an alpha-1,4 linkage, forming GlcNAcα1→4Galβ→R structures. These structures are predominantly found in gland mucin secreted by mucous cells in the stomach and Brunner's gland of the duodenum (Nakayama1999Expression; Unknownauthors2014Handbook).

A4GNT is primarily active in the Golgi apparatus of mucous cells, where it contributes to the synthesis of specific glycan structures in mucins, such as MUC5AC and MUC6. These glycan structures are essential for the protective and lubricative properties of mucosal surfaces, forming a barrier against the harsh gastric environment (Zhang2001Immunohistochemical; Unknownauthors2014Handbook). The enzyme shows a preference for core 2 branched oligosaccharides, efficiently incorporating GlcNAc into these structures (Nakayama2002α4NAcetylglucosaminyltransferase; Nakayama1999Expression).

In healthy human tissues, A4GNT's activity is crucial for maintaining the integrity of the gastric mucosal barrier, protecting against pathogens like Helicobacter pylori, and preventing gastric tumorigenesis (Unknownauthors2014Handbook).

## Clinical Significance
Mutations or alterations in the expression of the A4GNT gene, which encodes the enzyme alpha-1,4-N-acetylglucosaminyltransferase, have significant clinical implications, particularly in the development of gastric cancer. A4GNT is crucial for the biosynthesis of α1,4-linked N-acetylglucosamine (αGlcNAc), a component of gastric gland mucin. In A4GNT knockout (KO) mice, the absence of this enzyme leads to a complete lack of αGlcNAc expression, resulting in the spontaneous development of differentiated-type gastric adenocarcinoma. This suggests that αGlcNAc functions as a tumor suppressor, and its loss triggers gastric carcinogenesis through inflammation-associated pathways (Nakayama2016Function; Kawakubo2019Analysis).

In humans, the loss of αGlcNAc is associated with tumor progression and poor prognosis in differentiated-type gastric adenocarcinoma. This loss is linked to the upregulation of inflammatory chemokines, cytokines, and growth factors, which contribute to the carcinogenic process (Nakayama2016Function). Additionally, studies on A4GNT KO mice have shown that the absence of αGlcNAc leads to increased gastric epithelial cell proliferation and angiogenesis, processes that are mitigated by treatments such as Laminaran, a β-glucan derived from brown seaweed (Desamero2018Orally). These findings underscore the critical role of A4GNT in maintaining gastric mucosal integrity and preventing cancer development.


## References


[1. (Kawakubo2019Analysis) Masatomo Kawakubo, Hitomi Komura, Yukinobu Goso, Motohiro Okumura, Yoshiko Sato, Chifumi Fujii, Masaki Miyashita, Nobuhiko Arisaka, Satoru Harumiya, Kazuhiro Yamanoi, Shigenori Yamada, Shigeru Kakuta, Hiroto Kawashima, Michiko N. Fukuda, Minoru Fukuda, and Jun Nakayama. Analysis ofa4gntknockout mice reveals an essential role for gastric sulfomucins in preventing gastritis cystica profunda. Journal of Histochemistry &amp; Cytochemistry, 67(10):759–770, June 2019. URL: http://dx.doi.org/10.1369/0022155419860134, doi:10.1369/0022155419860134. This article has 3 citations.](https://doi.org/10.1369/0022155419860134)

[2. (Nakayama1999Expression) Jun Nakayama, Jiunn-Chern Yeh, Anup K. Misra, Susumu Ito, Tsutomu Katsuyama, and Minoru Fukuda. Expression cloning of a human α1,4-n-acetylglucosaminyltransferase that forms glcnacα1→4galβ→r, a glycan specifically expressed in the gastric gland mucous cell-type mucin. Proceedings of the National Academy of Sciences, 96(16):8991–8996, August 1999. URL: http://dx.doi.org/10.1073/pnas.96.16.8991, doi:10.1073/pnas.96.16.8991. This article has 143 citations.](https://doi.org/10.1073/pnas.96.16.8991)

[3. (Desamero2018Orally) Mark Joseph Desamero, Shigeru Kakuta, James Kenn Chambers, Kazuyuki Uchida, Satoshi Hachimura, Masaya Takamoto, Jun Nakayama, Hiroyuki Nakayama, and Shigeru Kyuwa. Orally administered brown seaweed-derived β-glucan effectively restrained development of gastric dysplasia in a4gnt ko mice that spontaneously develop gastric adenocarcinoma. International Immunopharmacology, 60:211–220, July 2018. URL: http://dx.doi.org/10.1016/j.intimp.2018.05.002, doi:10.1016/j.intimp.2018.05.002. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.intimp.2018.05.002)

[4. (Zhang2001Immunohistochemical) Mu Xia Zhang, Jun Nakayama, Eiko Hidaka, Seiko Kubota, Jing Yan, Hiroyoshi Ota, and Minoru Fukuda. Immunohistochemical demonstration of α1,4-n-acetylglucosaminyltransferase that forms glcnacα1,4galβ residues in human gastrointestinal mucosa. Journal of Histochemistry &amp; Cytochemistry, 49(5):587–596, May 2001. URL: http://dx.doi.org/10.1177/002215540104900505, doi:10.1177/002215540104900505. This article has 42 citations.](https://doi.org/10.1177/002215540104900505)

[5. (Nakayama2002α4NAcetylglucosaminyltransferase) Jun Nakayama. α4-N-Acetylglucosaminyltransferase, pages 151–157. Springer Japan, 2002. URL: http://dx.doi.org/10.1007/978-4-431-67877-9_20, doi:10.1007/978-4-431-67877-9_20. This article has 2 citations.](https://doi.org/10.1007/978-4-431-67877-9_20)

[6. (Unknownauthors2014Handbook) Handbook of glycosyltransferases and related genes. 2014. URL: http://dx.doi.org/10.1007/978-4-431-54240-7, doi:10.1007/978-4-431-54240-7. This article has 51 citations.](https://doi.org/10.1007/978-4-431-54240-7)

[7. (Nakayama2016Function) Jun Nakayama. Function of Unique O-Glycan Structures in Protecting Gastric Mucosa Against Helicobacter pylori Infection and Gastric Cancer Development, pages 111–124. Springer Japan, 2016. URL: http://dx.doi.org/10.1007/978-4-431-55939-9_7, doi:10.1007/978-4-431-55939-9_7. This article has 0 citations.](https://doi.org/10.1007/978-4-431-55939-9_7)